tiprankstipranks
Orthofix International N.V. (OFIX)
NASDAQ:OFIX
US Market

Orthofix (OFIX) Earnings Dates, Call Summary & Reports

Compare
74 Followers

Earnings Data

Report Date
May 13, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.53
Last Year’s EPS
-0.95
Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 25, 2025
|
% Change Since: -11.52%
|
Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
Orthofix delivered strong financial results in 2024 with record performance across major segments and robust growth in innovative areas like Spine and Orthopedics. Despite the positive momentum, the discontinuation of the M6 product lines and foreign currency challenges present notable headwinds. However, the company's proactive strategy to focus on profitable growth and innovation positions it well for the future.
Company Guidance
During the Orthofix Q4 2024 earnings call, the company provided guidance for 2025, highlighting several key metrics and strategic initiatives. Orthofix expects full-year 2025 net sales to range between $818 million to $826 million, reflecting constant currency growth of 6.5% year-over-year at the midpoint, excluding revenues from the discontinued M6 artificial disc product lines and accounting for a $4 million foreign currency headwind. The company projects non-GAAP adjusted EBITDA between $82 million and $86 million, indicating an 180 basis point margin expansion at the midpoint compared to 2024. Orthofix aims to sustain positive free cash flow, excluding restructuring charges from the M6 discontinuation. The guidance underscores confidence in sustainable growth driven by their differentiated portfolio and strategic focus on profitable growth initiatives, including new product launches in spine and orthopedics, leveraging the 7D FLASH Navigation System, and enhancing commercial strategies for deeper market penetration.
Record Financial Performance
Orthofix achieved record fourth quarter and full-year results in 2024, exceeding guidance with net sales of $215.7 million, reflecting an 8% year-over-year growth on a constant currency basis.
Spine Segment Growth
The U.S. spinal fixation business grew 12% year-over-year, with significant growth in the top 6 implant systems, thoracolumbar fixation, and interbody and cervical fusion.
Expansion of Bone Growth Therapy
Bone Growth Therapy (BGT) achieved record revenue and market expansion with a 9% growth in Q4, maintaining the #1 market share position in Spine and driving 10% growth in BGT Fracture.
Orthopedics Segment Achievements
The orthopedics business saw an 18% growth in Q4 with U.S. sales reaching a record 21% increase, led by products like TrueLok and Fitbone.
Innovation and Product Launches
Orthofix continued to innovate with several product launches planned for 2025, including the Reef L Lateral Lumbar Interbody and the TrueLok Elevate TBT system.
Positive Cash Flow and Financial Health
The company generated $21 million in positive free cash flow in the second half of 2024 and negotiated a favorable new term loan.
---

Orthofix (OFIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OFIX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 13, 20252025 (Q1)
-0.53 / -
-0.95
Feb 25, 20252024 (Q4)
-0.29 / -0.75
-0.59-27.12% (-0.16)
Nov 07, 20242024 (Q3)
-0.34 / -0.71
0.07-1114.29% (-0.78)
Aug 06, 20242024 (Q2)
-0.36 / -0.88
0.02-4500.00% (-0.90)
May 07, 20242024 (Q1)
-0.51 / -0.95
-0.1-850.00% (-0.85)
Mar 05, 20242023 (Q4)
0.06 / -0.59
0.19-410.53% (-0.78)
Nov 08, 20232023 (Q3)
-0.21 / 0.07
0.13-46.15% (-0.06)
Aug 08, 20232023 (Q2)
-0.60 / 0.02
0.08-75.00% (-0.06)
May 09, 20232023 (Q1)
-0.51 / -0.10
-0.10.00% (0.00)
Mar 06, 20232022 (Q4)
0.34 / 0.19
0.27-29.63% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

OFIX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 25, 2025$18.15$17.51-3.53%
Nov 07, 2024$18.40$18.22-0.98%
Aug 06, 2024$14.59$17.44+19.53%
May 07, 2024$13.46$13.89+3.19%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Orthofix International N.V. (OFIX) report earnings?
Orthofix International N.V. (OFIX) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
    What is Orthofix International N.V. (OFIX) earnings time?
    Orthofix International N.V. (OFIX) earnings time is at May 13, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OFIX EPS forecast?
          OFIX EPS forecast for the fiscal quarter 2025 (Q1) is -0.53.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis